Skip to main content
SpringerLink
Log in

Glucocorticoids and Lipocortin

  • Chapter
Pharmacology of the Skin II

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 87 / 2))

  • 341 Accesses

Abstract

The steroids are the most useful anti-inflammatory drugs that we possess, effective against virtually any type of inflammation. The naturally occurring hormone hydrocortisone is still used in clinical medicine, but in many cases it has been superseded by synthetic analogues which have vastly increased duration of action and potency, making them particularly valuable to the dermatologist. As a group, the steroidal anti-inflammatories are amongst the most widely prescribed drugs in the world.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aarsman AJ, Mynbeek G, Van Den Bosch H, Rothhut B, Prieur B, Cornera C, Jordon L, Russo-Marie F (1987) Lipocortin inhibtion of extracellular and intracellular phospho-lipase A2 is substrate concentration-dependent. FEBS Lett 219:76–180

    Article  Google Scholar 

  • Blackwell GJ (1983) Specificity and inhibition of glucocorticoid-induced macrocortin secretion from rat peritoneal macrophages. Br J Pharmacol 79:587–594

    PubMed  CAS  Google Scholar 

  • Blackwell GJ, Carnuccio R, di Rosa M, Flower RJ, Parente L, Persico P (1980) Macrocortin: a polypeptide causing the antiphospholipase effect of glucocorticoids. Nature 287:147–149

    Article  PubMed  CAS  Google Scholar 

  • Blackwell GJ, Carnuccio R, di Rosa M, Flower RJ, Langham CSJ, Parente L, Persico P et al. (1982) Glucocorticoids induce the formation and release of anti-inflammatory and anti-phospholipase proteins into the peritoneal cavity of the rat. Br J Pharmacol 76:185–194

    PubMed  CAS  Google Scholar 

  • Caliagnano A, Carnuccio R, di Rosa M, Ialenti A, Moncada S (1985) The anti-inflammatory effect of glucocorticoid-induced phospholipase inhibitory proteins. Agents Actions 16:60–62

    Article  Google Scholar 

  • Carnuccio R, di Rosa M, Flower RJ, Pinto A (1980) Hydrocortisone-induced inhibitor of prostaglandin biosynthesis in rat leukocytes. Br J Pharmacol 68:14–16

    PubMed  CAS  Google Scholar 

  • Carnuccio R, di Rosa M, Flower RJ, Pinto A (1981) The inhibition by hydrocortisone of prostaglandin biosynthesis in rat peritoneal leukocytes is correlated with intracellular macrocortin levels. Br J Pharmacol 74:322–324

    PubMed  CAS  Google Scholar 

  • Carnuccio R, di Rosa M, Guerrasio B, Iuvone T, Sautebin L (1987) Vasocortin, a novel glucocorticoid-induced anti-inflammatory protein. Br J Pharmacol 90:443–445

    PubMed  CAS  Google Scholar 

  • Cirino G, Flower RJ (1987 a) Human recombinant lipocortin I inhibits prostacyclin production by human umbilical artery. Prostaglandins 34:59–62

    Article  PubMed  CAS  Google Scholar 

  • Cirino G, Flower RJ (1987 b) The inhibitory effect of lipocortin on eicosanoid synthesis is dependent on divalent cation. Br J Pharmacol 92:521P

    Google Scholar 

  • Cirino G, Flower RJ, Browning J, Sinclair LK, Pepinsky RB (1987) Recombinant human lipocortin I inhibits thromboxane release from guinea-pig isolated perfused lung. Nature 328:270–272

    Article  PubMed  CAS  Google Scholar 

  • Cirino G, Peers SH, Flower RJ, Browning J, Pepinsky RB (1989) Human recombinant lipocortin I has acute local anti-inflammatory properties in the rat paw oedema test. Proc Natl Acad Sci USA (in press)

    Google Scholar 

  • Cloix JF, Colard O, Rothhut B, Russo-Marie F (1983) Characterisation and partial purification of “renocortins”, two polypeptides formed in renal cells causing the anti-phos-pholipase-like action of glucocorticoids. Br J Pharmacol 79:313–321

    PubMed  CAS  Google Scholar 

  • Danon A, Assouline G (1978) Inhibition of prostaglandin biosynthesis by corticosteroids requires RNA and protein synthesis. Nature 273:552–554

    Article  PubMed  CAS  Google Scholar 

  • Davidson FF, Dennis EA, Powell M, Glenney JR (1987) Inhibition of phospholipase A2 by “lipocortins” and calpactins. An effect of binding to substrate phospholipids. J Biol Chem 262:1698–1705

    PubMed  CAS  Google Scholar 

  • Dawes PT, Ilchyshyn A, Goulding NJ, Ilderton E, Shadforth MF, Yardley H, Hall ND (1987) Elevated epidermal PLA2 activity in RA: evidence against a circulating lipocortin antibody. Br J Rheumatol [Suppl 1]26:62

    Article  Google Scholar 

  • Di Rosa M, Persico P (1979) Mechanism of inhibtion of prostaglandin biosynthesis by hydrocortisone in rat leukocytes. Br J Pharmacol 66:161–163

    PubMed  Google Scholar 

  • Di Rosa M, Flower RJ, Hirata F, Parente L, Russo-Marie F (1984) Nomenclature announcement. Anti-phospholipase proteins. Prostaglandins 28:441–442

    Article  PubMed  Google Scholar 

  • Flower RJ (1984) Macrocortin and the antiphospholipase proteins. In: Weissman G (ed) Advances in inflammation research, vol 8. Raven, New York, p 1

    Google Scholar 

  • Flower RJ (1985) Background and discovery of lipocortins. Agents Actions 17:255–262

    Article  CAS  Google Scholar 

  • Flower RJ, Blackwell GJ (1979) Anti-inflammatory steroids induce biosynthesis of a phospholipase A2 inhibitor which prevents prostaglandin generation. Nature 278:456–459

    Article  PubMed  CAS  Google Scholar 

  • Flower RJ, Wood JN, Parente L (1984) Macrocortin and the mechanism of action of the glucocorticoids. In: Otterness I, Capetola R, Wong S (eds) Advances inflammation research, vol 7. Raven, New York, p 61

    Google Scholar 

  • Flower RJ, Moon-Parvin D, Peers SH, Pepinsky RB, Taylor RD (1986) A novel assay for assessing the binding of phospholipase A2 to substrate. Br J Pharmacol 89:743P

    Google Scholar 

  • Forster S, Ilderton E, Summerley R, Yardley HJ (1983) The level of phospholipase A2 activity is raised in the univolved epidermis of psoriasis. Br J Dermatol 108:103–105

    Article  PubMed  CAS  Google Scholar 

  • Forster S, Ilderton E, Norris JFB, Summerly R, Yardley HJ (1984) Characterization and activity of phospholipase A2 in normal human epidermis and lesion-free epidermis of patients with psoriasis or eczema. Br J Dermatol 112:135–147

    Article  Google Scholar 

  • Ghiara P, Meli R, Parente L, Perscio P (1984) Distinct inhibition of membrane-bound and lysosomal phospholipase A2 by glucocorticoid-induced proteins. Biochem Pharmacol 33:1445–1450

    Article  PubMed  CAS  Google Scholar 

  • Gryglewski RJ, Panczenko B, Korbut R, Grodzinska L, Ocetkiewicz A (1975) Corticosteroids inhibit prostaglandin release from perfused mesenteric blood vessies of rabbit and from perfused lungs of sensitized guinea-pigs. Prostaglandins 10:343–355

    PubMed  CAS  Google Scholar 

  • Gupta C, Goldman A (1982) H-2 histocompatibility region: influence on the murine glucocorticoid receptor and its response. Science 216:994–996

    Article  PubMed  CAS  Google Scholar 

  • Gupta C, Katsumo M, Goldman AS, Piddington R, Herold R (1984) Glucocorticoid-in-duced phospholipase A2 inhibitory proteins mediate glucocorticoid teratogenicity in vitro. Proc Natl Acad Sei USA 81:1140–1143

    Article  CAS  Google Scholar 

  • Hattori T, Hoffman T, Hirata F (1983) Differentitation of a histiocytic lymphoma cell line by lipomodulin, a phospholipase inhibitory protein. Biochem Biophys Res Commun 111:551–559

    Article  PubMed  CAS  Google Scholar 

  • Herbaczynska-Cedro K, Staszewska-Barczak J (1974) Adrenocortical hormones and the release of prostaglandin-like substances (PLS) (Abstr). 2nd Congress of the Hungarian Pharmacological Society, Budapest

    Google Scholar 

  • Hirata F (1981) The regulation of lipomodulin, a phospholipase inhibitory protein, in rabbit neutrophils by phosphorylation. J Biol Chem 256:7730–7733

    PubMed  CAS  Google Scholar 

  • Hirata F, Iwata M (1983) Role of lipomodulin, a phospholipase inhibitory protein, in im-munoregulation by thymocytes. J Immunol 130:1930–1936

    PubMed  CAS  Google Scholar 

  • Hirata F, Schiffmann E, Venkatasubramanian K, Salomon D, Axelrod J (1980) A phospholipase A2 inhibitory protein in rabbit neutrophils induced by glucocorticoids. Proc Natl Acad Sci USA 77:2533–2536

    Article  PubMed  CAS  Google Scholar 

  • Hirata F, Delcarmine R, Nelsom CA, Axelrod J, Schiffmann E, Warabi A, Deblas AL et al. (1981) Presence of autoantibody for phospholipase inhibitory protein(s) by radioim-muno-assay for lipomodulin. Biochem Biophys Res Commun 78:3190–3194

    CAS  Google Scholar 

  • Hirata F, Notsu Y, Iwata M, Parente L, di Rosa M, Flower RJ (1982) Identification of several species of phospholipase inhibitory protein(s) by radioimmuno-assay for lipomodulin. Biochem Biophys Res Commun 109:223–230

    Article  PubMed  CAS  Google Scholar 

  • Hirata F, Matsuda K, Notsu Y, Hattori T, Delcarmine R (1984) Phosphorylation at a tyrosine residue of lipomodulin in mitogen-stimulated murine thymocytes. Proc Natl Acad Sci USA 81:4717–4721

    Article  PubMed  CAS  Google Scholar 

  • Hirata F, Notsu Y, Yamada R, Ishihara Y, Wano Y, Kunos I, Kunos G (1985) Isolation and characterisation of lipocortin (lipomodulin) Agents Actions 17:263–266

    Article  CAS  Google Scholar 

  • Hong SC, Levine L (1976) Inhibition of arachidonic acid release from cells as the biochemical action of anti-inflammatory steroids. Proc Natl Acad Sci USA 73:1720–1734

    Article  Google Scholar 

  • Huang K-S, Wallner BP, Mattaliano RJ, Tizard R, Burne C, Frey A, Hession C et al. (1986) Two human 35 kd inhibitors of phospholipase A2 are related to substrates to pp60v-src and of the epidermal growth factor receptor/kinase. Cell 46:191–199

    Article  PubMed  CAS  Google Scholar 

  • Huang K-S, McGray P, Mattaliano RJ, Burne C, Chow EP, Sinclair LK, Pepinsky RB (1987) Purification and characterisation of proteolytic fragments of lipocortin I that inhibit phospholipase A2. J Biol Chem 262:7639–7645

    PubMed  CAS  Google Scholar 

  • Ilchyshyn A, Ilderton E, Kingsbury JA, Yardley HJ (1984) Evidence that the raised level of phospholipase A2 in the uninvolved epidermis of psoriasis is caused by hyperphos-phorylation of an inhibitor. Br J Dermatol 111:721–722

    Google Scholar 

  • Ilchyshyn A, Ilderton E, Yardley HJ (1985) Further evidence that the raised level of phospholipase A2 in lesion-free epidermis of psoriasis is caused by hyperpolarisation of an inhibitor. Br J Dermatol 112:135–147

    Article  Google Scholar 

  • Ilchyshyn A, Ilderton E, Pepinsky B, Yardley HJ (1986) Inhibition of phospholipase A2 activity in extracts of psoriatic epidermis by lipocortin. 4th International Symposium on Psoriasis, Stanford, USA

    Google Scholar 

  • Koltai M, Lepran I, Nemecz GY, Szekeres L (1983) The possible mechanism of protection induced by dexamethasone against sudden death due to coronary ligation in concious rats. Br J Pharmacol 79:327–329

    PubMed  CAS  Google Scholar 

  • Koltai M, Tosaki A, Adam G, Joo F, Nemecz G, Stezekeres L (1984) Prevention by mac-rocortin of global cerebral ischaemia in Sprague-Dawley rats. Eur J Pharmacol 105:347–350

    Article  PubMed  CAS  Google Scholar 

  • Koltai M, Kovacs Z, Nemecz G, Mecs I, Szekeres L (1987) Glucocorticoid-induced low molecular mass anti-inflammatory factors which do not inhibit phospholipase A2. Eur J Pharmacol 134:109–112

    Article  PubMed  CAS  Google Scholar 

  • Kretsinger RH, Creutz CE (1986) Consensus in exocytosis. Nature 320:573

    Article  PubMed  CAS  Google Scholar 

  • Nijkamp FP, Flower RJ, Moncada S, Vane JR (1976) Partial purification of rabbit aorta contracting substance-releasing factor and inhibition of its activity by anti-inflammatory steroids. Nature 263:479–482

    Article  PubMed  CAS  Google Scholar 

  • Nixon JS, Wilkinson SE, Davis P, Bloxham DP (1985) The inhibitory profiles of hog pancreatic and human rheumatoid synovial cell phospholipase A2. Agents Actions 17:299–301

    Article  CAS  Google Scholar 

  • Norris JFB, Ilderton E, Yardley HJ, Summerly R, Forster S (1984) Utilization of epidermal phospholipase A2 inhibition to monitor topical steroid action. Br J Dermatol [Suppl 27]121:195–203

    Article  Google Scholar 

  • Okamoto M, Ono T, Tojo H, Yamano T (1985 a) Immunochemical relatedness between secretory phospholipase A2 and intracellular phospholipase A2. Biochem Biophys Res Commun 128:788–794

    Article  PubMed  CAS  Google Scholar 

  • Okamoto M, Tojo H, Ono T, Yamano T (1985 b) Comparative study of intracellular and pancreatic phospholipase A2. Adv Prostaglandin Thromboxane Leukotriene Res 15:135

    CAS  Google Scholar 

  • Parente L, Flower RJ (1985) Hydrocortisone and “macrocortin” inhibit the zymosan-in-duced release of lyso-PAF from rat peritoneal leukocytes. Life Sci 36:1225–1231

    Article  PubMed  CAS  Google Scholar 

  • Parente L, di Rosa M, Flower RJ, Ghiara P, Meli R, Persico P, Salmon JA, Wood JN (1984) Relationship between the anti-phospholipase and anti-inflammatory effects of glucocorticoid-induced proteins. Eur J Pharmacol 99:233–239

    Article  PubMed  CAS  Google Scholar 

  • Peers SH, Taylor RD, Flower RJ (1987) A novel binding assay for phospholipase A2. Biochem Pharmacol 36:4287–4291

    Article  PubMed  CAS  Google Scholar 

  • Pepinsky RB, Sinclair LK (1986) Epidermal growth factor-dependent phosphorylation of lipocortin. Nature 321:81–84

    Article  PubMed  CAS  Google Scholar 

  • Pepinsky RB, Sinclair LK, Browning JL, Mattaliano RJ, Tizard R, Burnes C, Frey A et al. (1986) Two human 35 kd inhibitors of phospholipase A2 are related to substrates of pp60v-src and of the epidermal growth factor receptor kinase. Cell 46:191–199

    Article  Google Scholar 

  • Podgorski MR, Goulding NJ, Hall ND, Flower RJ, Maddison PJ, Pepinsky RB (1987) Autoantibodies to recombinant lipocortin in RA and SLE. Br J Rheumatol [Suppl l]26:54–55

    Google Scholar 

  • Rothhut B, Russo-Marie F, Wood J, di Rosa M, Flower RJ (1983) Further characterisation of the glucocorticoid-induced anti-phospholipase protein “renocortin”. Biochem Biophys Res Commun 117:878–884

    Article  PubMed  CAS  Google Scholar 

  • Rothhut B, Cumera C, Prieur B, Errasfa M, Minassion G, Russo-Marie F (1987) Purification and characterisation of a 32 kDa phospholipase A2 inhibitory protein (lipocortin) from human peripheral blood mono-nuclear cells. FEBS Lett 219:169–175

    Article  PubMed  CAS  Google Scholar 

  • Russo-Marie F, Duval D (1982) Dexamethasone-induced inhibition of prostaglandin production does not result from a direct action on phospholipase activities but is mediated through a steroid-inducible factor. Biochim Biophys Acta 712:177–185

    PubMed  CAS  Google Scholar 

  • Russo-Marie F, Paing M, Duval D (1979) Involvement of glucocorticoid receptors in steroid-induced inhibition of prostaglandin synthesis. J Biol Chem 254:8498–8504

    PubMed  CAS  Google Scholar 

  • Saris CJM, Tack BF, Kristensen T, Glenney JR, Hunter T (1986) The cDNA sequence for the protein-tyrosine kinase substrate p36 (calpactin 1 heavy chain) reveals a multi-domain protein with internal repeats. Cell 46:201–212

    Article  PubMed  CAS  Google Scholar 

  • Schlaepfer DD, Haigier HT (1987) Characterisation of Ca2+-dependent phospholipid binding and phosphorylation of lipocortin I. J Biol Chem 262:6931–6937

    PubMed  CAS  Google Scholar 

  • Touqui L, Rothhut B, Shaw AM, Fradin A, Vargaftig BB, Russo-Marie F (1986) Platelet activation — a role for a 40k anti-phospholipase A2 protein indistinguishable from lipocortin. Nature 321:177–180

    Article  PubMed  CAS  Google Scholar 

  • Tsurufuji S, Sugio K, Takemasa F (1979) The role of glucocorticoid receptor and gene expression in the anti-inflammatory action of dexamethasone. Nature 280:408–410

    Article  PubMed  CAS  Google Scholar 

  • Van de Velde VJS, Bult H, Herman AG (1985) Dexamethasone and prostacyclin biosynthesis by serosal membranes of the rabbit peritoneal cavity. Agents Actions 17:308–309

    Article  Google Scholar 

  • Volwerk JJ, de Haas GH (1982) Pancreatic phospholipase A2: a model for membrane-bound enzymes? In: Jost PC, Griffiths OH (eds) Lipid-protein interactions, vol 1. Wiley, New York, pp 69–149

    Google Scholar 

  • Wallner BP, et al. (1986) Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature 320:77–81

    Article  PubMed  CAS  Google Scholar 

  • Yedgar S, Reisfeld N, Dagan A (1986) Synthesis of cell-impermeable inhibitor of phospholipase A2. FEBS Lett 200:165–168

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. S. H. Peers
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. J. Flower
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. The Institute of Dermatology, St. Thomas’s Hospital, Lambeth Palace Road, SE1 7EH, London, Great Britain

    Malcolm W. Greaves M.D., Ph.D., F.R.C.P.

  2. Department of Dermatology, The Royal Victoria Infirmary, The University of Newcastle upon Tyne, NE1 4LP, Newcastle upon Tyne, Great Britain

    Sam Shuster M.D., Ph. D., F.R.C.P.

Rights and permissions

Reprints and permissions

Copyright information

© 1989 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Peers, S.H., Flower, R.J. (1989). Glucocorticoids and Lipocortin. In: Greaves, M.W., Shuster, S. (eds) Pharmacology of the Skin II. Handbook of Experimental Pharmacology, vol 87 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74054-1_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74054-1_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74056-5

  • Online ISBN: 978-3-642-74054-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation